Induction chemotherapy followed by Cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: Results of the GORTEC 2007-02 phase III randomized tria
Key Publications on NACT and Targeted therapies in head and neck cancer
Chairpersons :
Alok Thakar, Krishnakumar Thankappan, K. S. Gopinath
Reviewer :
Mohit Sharma